Cytiva
Trending Articles
Related Content
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
The path toward autonomous biopharma manufacturing
By connecting physical automation, robotics, AI and process knowledge into learning systems that accelerate development while preserving quality, safety and scientific rigour, the industry's next transformation is autonomous CMC development and manufacturing
Digital
Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery
The company has introduced its new Biacore 8S and 8S+ surface plasmon resonance systems, combining high-throughput screening, molecular characterisation and automated workflows to support faster and more confident drug discovery
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Digital
Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing
The pair have jointly launched an open-architecture supervisory control platform, designed to integrate across multiple instrument vendors and modalities, providing biopharma manufacturers with unified real-time process oversight from development through to commercial scale
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
Cytiva enters research partnership with SRTIGET for next-gen genomic medicine
The pair aim to expand the role of lipid nanoparticle technology into gene therapy delivery, including applications in cancer and inherited blood diseases, CNS delivery for neurological disorders where current methods fail and in vivo stem cell modification that could eliminate toxic conditioning regimens